Umesh Laddha

About

Dr. Laddha is a distinguished pharmaceutical researcher with a Ph.D. from Savitribai Phule Pune University, Pune, and post-doctoral research credentials from Regeron, South Korea. His academic and research journey is marked by notable achievements, including a research grant of ₩5 million from the Korean Society of Ginseng and a ₹64 lakh FIST grant from the Department of Science and Technology (DST), Government of India.

Dr. Laddha has made significant contributions to scientific literature, having published 34 research articles in journals indexed by Scopus and Web of Science, with a cumulative impact factor of 85. In addition, he has authored 12 books and contributed 20 book chapters, reflecting his deep expertise and commitment to academic scholarship.

His role as a reviewer for prominent scientific publishers such as Springer, Elsevier, and Taylor & Francis further underscores his standing in the research community. He holds 11 granted intellectual property rights (IPRs), has received 17 awards in recognition of his contributions, and successfully completed three industrial research projects.

Through his scholarly work, innovation, and dedication, Dr. Laddha continues to exemplify excellence in the field of pharmaceutical sciences.

Employment

• MET Institute of Pharmacy Assistant Professor
  2017 - Present
• R C Patel Institute of Pharmaceutical Education and Research Assistant Professor
  2015 - 2017

Education

• Savitribai Phule Pune University PhD
  2018 - 2021

Projects & Funding

Projects & funding information is unavailable.

Publications (41)

• An integrative review on disease pathogenesis, diagnostic techniques, management strategies, and futuristic innovations in ocular malignancies
  International Ophthalmology 2026 DOI: 10.1007/s10792-026-04176-7
  +Save
• A narrative review on the role of herbal constituents and their combination with nanotechnology as future hope in the management of diabetic retinopathy
  Next Nanotechnology 2026 DOI: 10.1016/j.nxnano.2026.100409
  +Save
• Naringenin and quercetin nanoparticles as a dual strategy for topical management of diabetic retinopathy
  Next Nanotechnology 2026 DOI: 10.1016/j.nxnano.2025.100332
  +Save
• Ginseng-loaded nanostructured lipid gels for nose-to-brain targeted modulation of 5-HT receptors in cognitive disorders
  Next Materials 2026 DOI: 10.1016/j.nxmate.2026.101588
  +Save
• A narrative review on artificial intelligence in advanced drug delivery systems: Nanomedicine, GEMs and smart robotics
  Next Nanotechnology 2026 DOI: 10.1016/j.nxnano.2026.100581
  +Save
• An overview on developing the formulation to keep away the food impact on absorption
  Next Nanotechnology 2025 DOI: 10.1016/j.nxnano.2025.100186
  +Save
• Navigating psoriasis: From immune mechanisms to natural healing approaches
  International Immunopharmacology 2025 DOI: 10.1016/j.intimp.2024.113626
  +Save
• Insight into Suitable Polymers and Materials for the Preparation of Novel Drug Delivery Systems
  Novel Drug Delivery Systems in the Management of Chronic Diseases 2024 DOI: 10.1201/9781032654881-4
  +Save
• THE IMPORTANCE OF NUTRIGENETICS AND NUTRIGENOMICS FOR FUNCTIONAL FOODS AND PERSONALIZED NUTRITION
  Nutrigenomics and Nutraceuticals 2024
  +Save
• Overview of Chronic Diseases
  Novel Drug Delivery Systems in the Management of Chronic Diseases 2024 DOI: 10.1201/9781032654881-2
  +Save